Related Experiment Video
Updated: Jun 3, 2026

A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
Health care resource use and costs among patients with cushing disease
Brooke Swearingen1, Ning Wu, Shih-Yin Chen
1Neuroendocrine Clinical Center, Massachusetts General Hospital, Boston, Massachusetts, USA. BSwearingen@partners.org
Insights
Patients with Cushing disease incur higher health care costs due to comorbidities. Successful surgery reduces these costs, while unsuccessful surgery increases them, highlighting the economic impact of treatment outcomes.
Area of Science:
- Endocrinology
- Health Economics
- Surgical Outcomes
Background:
- Cushing disease is associated with significant comorbidities.
- Understanding the economic burden of Cushing disease is crucial for healthcare planning.
Purpose of the Study:
- To evaluate healthcare expenditures in Cushing disease patients.
- To determine the impact of surgical treatment on overall and comorbidity-related costs.
Main Methods:
- Retrospective cohort study using insurance claims data (2004-2008).
- Patients with Cushing disease were matched with controls (nonfunctioning pituitary adenomas and population controls).
- Analysis of comorbidities and annual direct healthcare costs, comparing pre- and post-operative periods based on remission status.
Main Results:
- Cushing disease patients exhibited higher rates of hypertension, diabetes mellitus, and hyperlipidemia.
- Total annual healthcare costs were significantly higher for Cushing disease patients compared to controls.
- Successful surgery led to decreased outpatient costs and a trend of reduced overall costs; unsuccessful surgery correlated with increased postoperative costs.
Conclusions:
- Cushing disease patients present with more comorbidities and higher healthcare costs.
- Surgical success in Cushing disease is linked to reduced healthcare expenditures.
- Treatment failure results in increased healthcare costs, emphasizing the importance of effective surgical intervention.
Objective:
To assess health care costs associated with Cushing disease and to determine changes in overall and comorbidity-related costs after surgical treatment.
Methods:
In this retrospective cohort study, patients with Cushing disease were identified from insurance claims databases by International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) codes for Cushing syndrome (255.0) and either benign pituitary adenomas (227.3) or hypophysectomy (07.6×) between 2004 and 2008. Each patient with Cushing disease was age- and sex-matched with 4 patients with nonfunctioning pituitary adenomas and 10 population control subjects. Comorbid conditions and annual direct health care costs were assessed within each calendar year. Postoperative changes in health care costs and comorbidity-related costs were compared between patients presumed to be in remission and those with presumed persistent disease.
Results:
Of 877 identified patients with Cushing disease, 79% were female and the average age was 43.4 years. Hypertension, diabetes mellitus, and hyperlipidemia were more common among patients with Cushing disease than in patients with nonfunctioning pituitary adenomas or in control patients (P<.01). For every calendar year studied, patients with Cushing disease had significantly higher total health care costs (2008: $26 440 [Cushing disease] vs $13 708 [nonfunctioning pituitary adenomas] vs $5954 [population control], P<.01). Annual outpatient costs decreased significantly for patients in remission after surgery, and there was a trend towards improvement in overall disease-related costs with remission. A significant increase in postoperative health care costs was observed in those patients not in remission.
Conclusions:
Patients with Cushing disease had more comorbidities than patients with nonfunctioning pituitary adenomas or control patients and incurred significantly higher annual health care costs; these costs decreased after successful surgery and increased after unsuccessful surgery.
More Related Videos
06:16Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
10:38Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies
Published on: January 16, 2019
Related Concept Videos
Cushing Syndrome I: Introduction
Cushing Syndrome II: Pathophysiology
Adrenal Gland Disorders
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic illness...
Drug Dosing: Obese Patients
Chronic Pancreatitis II: Collaborative Care
Assessment: